BAILII is celebrating 24 years of free online access to the law! Would you consider making a contribution?
No donation is too small. If every visitor before 31 December gives just £5, it will have a significant impact on BAILII's ability to continue providing free access to the law.
Thank you very much for your support!
 |
[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback] | |
United Kingdom Statutory Instruments |
||
|
You are here: BAILII >> Databases >> United Kingdom Statutory Instruments >> The National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2017 No. 296 URL: http://www.bailii.org/uk/legis/num_reg/2017/uksi_2017296_en_1.html |
||
[New search] [Printable PDF version] [Help]
Statutory Instruments
National Health Service, England
Made
1st March 2017
Laid before Parliament
9th March 2017
Coming into force
1st April 2017
The Secretary of State for Health makes the following Regulations in exercise of the powers conferred by sections 3B(1) and 272(7)(a) and (b) of the National Health Service Act 2006(1).
In accordance with section 3B(4) of that Act, the Secretary of State obtained appropriate advice and consulted the National Health Service Commissioning Board before deciding to make these Regulations.
1. These Regulations may be cited as the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) (Amendment) Regulations 2017 and come into force on 1st April 2017.
2.-(1) Schedule 4 (services for rare and very rare conditions) to the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012(2) is amended as follows.
(2) After paragraph 140A, insert-
"140B. Uterine transplantation services.".
Signed by authority of the Secretary of State for Health.
O'Shaughnessy
Parliamentary Under-Secretary of State,
Department of Health
1st March 2017
(This note is not part of the Regulations)
These Regulations amend Schedule 4 to the National Health Service Commissioning Board and Clinical Commissioning Groups (Responsibilities and Standing Rules) Regulations 2012 (S.I. 2012/2996) ("the principal Regulations"). Schedule 4 to the principal Regulations specifies services for rare and very rare conditions which the National Health Service Commissioning Board ("the Board") must arrange for the provision of, as part of the health service.
Regulation 2 amends Schedule 4 to give effect to the revised commissioning responsibilities for the Board pursuant to regulations 7, 10 and 11 of the principal Regulations.
This amendment follows advice received, and consultation with the Board, pursuant to the statutory procedures set out in section 3B(4) of the National Health Service Act 2006.
No impact assessment has been produced for these Regulations as they have no impact on the private sector and civil society organisations, and no significant effect on the public sector.
2006 c.41. Section 3B of the National Health Service Act 2006 ("the 2006 Act") was inserted by section 15 of the Health and Social Care Act 2012. By virtue of section 271(1) of the 2006 Act, the powers exercised in making these Regulations are exercisable by the Secretary of State in relation to England only. See section 275(1) of the 2006 Act for the definitions of "prescribed" and "regulations".
S.I. 2012/2996; relevant amendments to which were made by S.I. 2014/452, 2015/415 and 2016/293.
